A new Moffitt Cancer Center study indicated that men who are
on androgen deprivation therapy have greater odds of experiencing impaired cognitive function.
Not exact matches
The authors focused
on men newly diagnosed with localized (non-metastatic) prostate cancer in 1995 - 2011 and treated with radical prostatectomy, brachytherapy, radiation therapy, or primary
androgen deprivation therapy (PADT).
In current practice, men newly diagnosed with prostate cancer that has spread widely, and whose cancer depends
on male hormones to grow, are started
on hormone - blocking medications —
androgen deprivation therapy (ADT).